Angiogenic potential of YKL-40 in the dynamics of tumor niche
dc.contributor.author | Pouyafar, A | |
dc.contributor.author | Heydarabad, MZ | |
dc.contributor.author | Mahboob, S | |
dc.contributor.author | Mokhtarzadeh, A | |
dc.contributor.author | Rahbarghazi, R | |
dc.date.accessioned | 2018-08-26T07:11:51Z | |
dc.date.available | 2018-08-26T07:11:51Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44494 | |
dc.description.abstract | A multitude of clinical studies showed the elevation of YKL-40 in subjects with different kinds of tumors. It is predicted that an inherent correlation exists between survivals of cancer patients with total YKL-40 serum levels, making this factor as a potential novel biomarker. However, the crucial role of YKL-40 in the dynamics of cancers, especially angiogenesis, has not yet been completely addressed. In this review, we highlighted the various facets of YKL-40 and its importance in cancer biology as a bio-shuttle in gene therapy. | |
dc.language.iso | English | |
dc.relation.ispartof | BIOMEDICINE & PHARMACOTHERAPY | |
dc.subject | Cancer biology | |
dc.subject | Angiogenesis | |
dc.subject | YKL-40 factor | |
dc.title | Angiogenic potential of YKL-40 in the dynamics of tumor niche | |
dc.type | Article | |
dc.citation.volume | 100 | |
dc.citation.spage | 478 | |
dc.citation.epage | 485 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1016/j.biopha.2018.02.050 |
فایلهای درون آیتم
فایلها | سایز | فرمت | نمایش |
---|---|---|---|
هیچ فایل مرتبطی وجود ندارد |